Gene · 8764
Papers3,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 3,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of costimulatory molecules in glioma biology and immune microenvironment. | Front Genet | 2022 | 36437961 | PubTator, text mining | PubMed |
| HOXA-AS2 may be a potential prognostic biomarker in human cancers: A meta-analysis and bioinformatics analysis. | Front Genet | 2022 | 36437956 | PubTator, text mining | PubMed |
| A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma. | Nat Commun | 2022 | 36433984 | PubTator, text mining | PubMed |
| Learning from TCR Signaling and Immunological Synapse Assembly to Build New Chimeric Antigen Receptors (CARs). | Int J Mol Sci | 2022 | 36430728 | PubTator, text mining | PubMed |
| A New Prognostic Signature Constructed with Necroptosis-Related lncRNA in Bladder Cancer. | J Oncol | 2022 | 36425941 | PubTator, text mining | PubMed |
| Characterisation of the immune microenvironment of primary breast cancer and brain metastasis reveals depleted T-cell response associated to ARG2 expression. | ESMO Open | 2022 | 36423363 | PubTator, text mining | PubMed |
| Can we consider soluble herpes virus entry mediator (sHVEM) as a tumor marker? | Caspian J Intern Med | 2022 | 36420330 | PubTator, text mining | PubMed |
| CD160 receptor in CLL: Current state and future avenues. | Front Immunol | 2022 | 36420268 | PubTator, text mining | PubMed |
| Pan-cancer analysis supports MAPK12 as a potential prognostic and immunotherapeutic target in multiple tumor types, including in THCA. | Oncol Lett | 2022 | 36420075 | PubTator, text mining | PubMed |
| Molecular determinants of the interaction between HSV-1 glycoprotein D and heparan sulfate. | Front Mol Biosci | 2022 | 36419932 | PubTator, text mining | PubMed |
| Immunometabolic profiling of cervicovaginal lavages identifies key signatures associated with adenomyosis. | iScience | 2022 | 36419846 | PubTator, text mining | PubMed |
| A Novel Glycolysis-Related Long Noncoding RNA Signature for Predicting Overall Survival in Gastric Cancer. | Pathol Oncol Res | 2022 | 36419649 | PubTator, text mining | PubMed |
| A single-cell human islet interactome atlas identifies disrupted autocrine and paracrine communications in type 2 diabetes. | NAR Genom Bioinform | 2022 | 36415826 | PubTator, text mining | PubMed |
| A novel ten-gene prognostic signature for cervical cancer based on CD79B-related immunomodulators. | Front Genet | 2022 | 36406115 | PubTator, text mining | PubMed |
| A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer. | Front Immunol | 2022 | 36405735 | PubTator, text mining | PubMed |
| The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy. | Front Immunol | 2022 | 36405727 | PubTator, text mining | PubMed |
| Integrating Single-cell RNA-seq to construct a Neutrophil prognostic model for predicting immune responses in non-small cell lung cancer. | J Transl Med | 2022 | 36401283 | PubTator, text mining | PubMed |
| Editorial: Genetic basis of tolerance induction defects underlying the development of autoimmune pathologies. | Front Immunol | 2022 | 36389740 | PubTator, text mining | PubMed |
| Genomic landscape of the immunogenicity regulation in skin melanomas with diverse tumor mutation burden. | Front Immunol | 2022 | 36389735 | PubTator, text mining | PubMed |
| Checkpoint inhibitors as immunotherapy for fungal infections: Promises, challenges, and unanswered questions. | Front Immunol | 2022 | 36389687 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8764/papers?page=45